Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.

Journal of Korean medical science

Volumn 25, Issue 6, 2010, Pages 882-887

  Paik, Yong Han ^a   Kim, Ja Kyung ^b   Kim, Do Young ^b   Park, Jun Yong ^b   Ahn, Sang Hoon ^b   Han, Kwang Hyub ^b   Chon, Chae Yoon ^b   Lee, Kwan Sik ^b  

^a Yonsei University College of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HEPATITIS B; HUMAN; MALE; MIDDLE AGED; RECURRENT DISEASE; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956410703     PISSN: None     EISSN: 15986357     Source Type: Journal    
DOI: None     Document Type: Article

References (0)